Bo Su
Hengyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Diallyl Trisulfide Intervention in Redox Homeostasis and Its Multitarget Antitumor Effects.
Journal: Journal of agricultural and food chemistry
Published: June 19, 2025
DADS Regulates EMT and Chemotherapy Resistance by Inhibiting RORα/β-Catenin Signaling through PKCα-Dependent Phosphorylation in Gastric Cancer.
Journal: Oncology research
Published: June 04, 2025
The critical role of X-linked inhibitor of apoptosis protein (XIAP) in tumor development.
Journal: Apoptosis : an international journal on programmed cell death
Published: March 08, 2025
Highly integrated automatic injection terahertz microfluidic biosensor based on metasurface and LT-GaAs photoconductive antenna.
Journal: Optics express
Published: June 11, 2024
Diallyl disulfide antagonizes DJ-1 mediated proliferation, epithelial-mesenchymal transition, and chemoresistance in gastric cancer cells.
Journal: Environmental toxicology
Published: January 02, 2024
Oridonin promotes RSL3-induced ferroptosis in breast cancer cells by regulating the oxidative stress signaling pathway JNK/Nrf2/HO-1.
Journal: European journal of pharmacology
Published: November 22, 2023
Diallyl disulfide inhibits proliferation, epithelial-mesenchymal transition, and invasion through RORα-mediated downregulation of Wnt1/β-catenin pathway in gastric cancer cells.
Journal: Journal of food and drug analysis
Published: May 27, 2022
Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway.
Journal: Cancer letters
Published: March 04, 2020
RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway.
Journal: Frontiers in oncology
Published: September 15, 2019
Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer.
Journal: Oncology reports
Published: August 28, 2017
Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
Journal: Oncotarget
Published: October 21, 2015
Last Updated: 09/26/2026